Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 752-759

  Zangwill, Kenneth M ^a   Vadheim, Constance M ^b   Vannier, Ann M ^b   Hememvay, Leslie S ^b   Greenberg, David P ^b   Ward, Joel I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CHILD; DRUG CONJUGATION; DRUG DESIGN; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0029816056     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.752     Document Type: Article

References (12)

1. Williams WW, Hickson NIA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1989;108:616-25.
2. Centers for Disease Control. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989;38:64-76.
3. Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992; 165(suppl 1):S49-52.
4. Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influence type b disease in Southern California. Arch Pediatr Adolesc Med 1994;148:51-6.
5. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Broome CV, Wenger JD. Decline of childhood Haemophilus influenzas type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
6. Anderson EL, Kennedy DJ, Geldmacher KM, et al. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996; 128:649-53.
7. King JC, Vink P, Smilie M, et al. Safety and immunogenicity of a 5valent conjugate pneumococcal vaccine (CPV) in H1V (+) and non-HIV infected (-) children [abstract 1064]. Pediatr Res 1995;37:180A.
8. Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
9. Schutze GE, Kaplan SL, Jacobs RF. Resistant pneumococcus: a worldwide problem. Infection 1994;22:233-7.
10. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multi-drug resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995;14:745-50.
11. Hofmann J, Cetron MS, Parley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
12. American Academy of Pediatrics. Pneumococcal infections. In: Peter G, ed. 1994 red book: report of the Committee on Infectious Diseases. 23rd ed. Elk Grove, IL: American Academy of Pediatrics, 1994:371.